Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D015068:17-Ketosteroids / Q000097:blood; D000324:Adrenocorticotropic Hormone / Q000097:blood; D003480:Cushing Syndrome / Q000097:blood / Q000188:drug therapy*; D003533:Cyproheptadine / Q000627:therapeutic use*; D003907:Dexamethasone; D004298:Dopamine / Q000502:physiology; D004873:Ergolines / Q000627:therapeutic use*; D006854:Hydrocortisone / Q000097:blood; D008711:Metergoline / Q000627:therapeutic use*; D010902:Pituitary Gland / Q000503:physiopathology*; D012701:Serotonin / Q000502:physiology
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004873:Ergolines; D008711:Metergoline; D003533:Cyproheptadine; D012701:Serotonin; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D004298:Dopamine; D006854:Hydrocortisone